Find the latest for Ayana Bio company news
After her husband passed away from ALS, Indu Navar started an organization that uses AI to study ALS and other neurological diseases.
The brother goes on vision quests. The sister is a former English major. Together, they defected from OpenAI, started Anthropic, and built (they say) AI's most upstanding citizen, Claude.
The deal will bring flagship model Claude, to thousands of corporate customers, including Comcast, Conde Nast and Block.
Aiforia and Techcyte announce strategic collaboration to advance AI-powered digital pathology Aiforia Technologies Plc, Press Release, March 21, 2025 at 09:00 a.m. EET Aiforia, a trusted provider of d
Another company involved in using AI to repurpose failed drugs - as well as drugs that have already been approved - is BioXcel Therapeutics. Unlike Ignota, however, the company focuses on compounds that have already demonstrated safety in prior clinical trials, but have been discontinued by their developers for various other reasons.
Cohere for AI, Cohere's nonprofit research lab, has released an 'open' multimodal AI model, Aya Vision, the lab claims is best-in-class.
UNC Charlotte researchers are contributing to pioneering breakthroughs in cancer therapeutics, communicable disease forecasting and prevention, optical applications for health care, and use of AI and other innovative computational tools — and more.
A year before Elon Musk helped start OpenAI in San Francisco, philanthropist and Microsoft co-founder Paul Allen already had established his own nonprofit artificial intelligence research laboratory in Seattle.